Advances in Cystic Fibrosis treatment and medication and therapy adherence





The interactive transcript could not be loaded.



Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 14, 2016

Anne Olscher, COO of the Intelligent Health Association ( ihassociation.org) interviews Dr. Chris Landon on advances in Cystic Fibrosis treatment and new technologies in medication and therapy adherence.

The interview was shot live at the Intelligent Health Pavilion at HIMSS16 and can also be seen at intelligenthospital.tv (IHTV)

Dr. Chris Landon is CEO of the Technology Development Center Laboratories & Studio. Dr. Landon serves CareThings as Chief Medical Officer. Board certified in pediatrics and pediatric pulmonology, Landon received his medical degree from the University of Southern California and is currently a Clinical Associate Professor of Pediatrics. He completed his internship and residency in pediatrics at Stanford University Hospital and a fellowship in allergy, immunology and respiratory diseases at the Children's Hospital at Stanford.Dr. Chris Landon is Director of the Pediatric Diagnostic Center, a pediatric multi-specialty referral clinic dedicated to treating children with every-day health problems as well as those needing specialized care. Landon is Director Of Pediatrics at the UCLA affiliates Family Medicine Residency and is Clinical Assistant Professor of Family Medicine at UCLA.

Landon has been actively involved in medical diagnosis and teaching utilizing telemedicine for three decades. Initially funded through USDA and Blue Cross rural telemedicine grants Landon now oversees the local California Telehealth Network implementation and the Hospital Escuela implementation in Tegucigalpa, Honduras. Landon established local telemedicine teaching for the Pediatric Nurse Practitioner training program at California State University Long Beach and is working with CHLA to establish tele-ophthalmology services.

Dr. Landon’s research interests have led to device development for remotely observed therapy and diagnosis with the Vivometrics LifeShirt, expanded uses of medical devices across disease states with the Hill-Rom VEST, and an increased awareness of the effects on patients and families of new therapies.

Through the Landon Pediatric Foundation, a nonprofit corporation benefiting the health of underserved children, medical services are provided, medical education, support of recreational activities, and research leading to healthy eating and active living.

What is the Intelligent Health Association (IHA)?

The IHA is a new, growing organization built on the success of the “RFID in Healthcare Consortium” (RHCC), founded in 2008 to serve the growing industry needs of the Auto-ID and RFID/RTLS technology sector. The RHCC is now an active member of the IHA.

The IHA is an international, technology centric and technology focused organization serving as the parent organization and home for many 21st century digital technologies. The IHA is comprised of many new digital/mobile technology communities and societies, all operating under one organizational structure with a common goal: to help drive the “Evolution to the Digital Health Revolution™” through the adoption and implementation of new technologies in the health ecosystem. The IHA accomplishes its mission through the delivery of vendor neutral, technology agnostic educational programs at conferences, trade shows, webinars and via social media channels in a partnership with other health related organizations, academic institutions, government, technology community and standards bodies. For further information please contact Harry P. Pappas, Founder and CEO, the Intelligent Health Association: hpappas@ihassociation.org

Comments are disabled for this video.

to add this to Watch Later

Add to

Loading playlists...